Roberta J. Melander

798 total citations
31 papers, 625 citations indexed

About

Roberta J. Melander is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Roberta J. Melander has authored 31 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Medicine, 20 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Roberta J. Melander's work include Antibiotic Resistance in Bacteria (24 papers), Cancer therapeutics and mechanisms (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Roberta J. Melander is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Cancer therapeutics and mechanisms (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Roberta J. Melander collaborates with scholars based in United States, United Kingdom and Philippines. Roberta J. Melander's co-authors include Christian Melander, Akash Basak, Robert K. Ernst, William T. Barker, Courtney E. Chandler, Leigh A. Jania, Beverly H. Koller, John Cavanagh, Richele J. Thompson and Aparna Krishnamurthy and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Roberta J. Melander

27 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta J. Melander United States 14 330 277 124 106 96 31 625
Steven M. Kwasny United States 10 330 1.0× 312 1.1× 144 1.2× 76 0.7× 98 1.0× 17 685
Roberta J. Melander United States 16 345 1.0× 201 0.7× 174 1.4× 111 1.0× 144 1.5× 36 757
Shannon B. Falconer Canada 8 343 1.0× 269 1.0× 77 0.6× 105 1.0× 131 1.4× 9 703
Evan Martens United States 7 297 0.9× 173 0.6× 146 1.2× 111 1.0× 83 0.9× 8 730
Soumya Ramu Australia 17 308 0.9× 180 0.6× 183 1.5× 78 0.7× 95 1.0× 19 764
Maxime Gualtiéri France 15 304 0.9× 160 0.6× 109 0.9× 65 0.6× 108 1.1× 25 705
Julieanne M. Bostock United Kingdom 16 409 1.2× 180 0.6× 123 1.0× 111 1.0× 133 1.4× 21 747
Timothy R. Kane Canada 5 287 0.9× 255 0.9× 88 0.7× 71 0.7× 83 0.9× 5 797
Rafael Ayerbe-Algaba Spain 10 210 0.6× 248 0.9× 64 0.5× 66 0.6× 85 0.9× 17 540
Congran Li China 17 429 1.3× 213 0.8× 50 0.4× 74 0.7× 120 1.3× 58 826

Countries citing papers authored by Roberta J. Melander

Since Specialization
Citations

This map shows the geographic impact of Roberta J. Melander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta J. Melander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta J. Melander more than expected).

Fields of papers citing papers by Roberta J. Melander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta J. Melander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta J. Melander. The network helps show where Roberta J. Melander may publish in the future.

Co-authorship network of co-authors of Roberta J. Melander

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta J. Melander. A scholar is included among the top collaborators of Roberta J. Melander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta J. Melander. Roberta J. Melander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melander, Roberta J., et al.. (2025). Mechanisms of antibiofilm compounds JG-1 and M4 across multiple species: alterations of protein interactions essential to biofilm formation. Frontiers in Cellular and Infection Microbiology. 15. 1631575–1631575.
2.
3.
Melander, Roberta J., et al.. (2025). 2-Aminoimidazole-benzimidazole Conjugates Potentiate the Gram-Positive Selective Antibiotic Clarithromycin against Acinetobacter baumannii. ACS Medicinal Chemistry Letters. 16(8). 1562–1568.
4.
Melander, Roberta J., et al.. (2024). Identification of a 2‐Aminobenzimidazole Scaffold that Potentiates Gram‐Positive Selective Antibiotics Against Gram‐Negative Bacteria. ChemBioChem. 25(8). e202400127–e202400127. 3 indexed citations
5.
Melander, Roberta J., et al.. (2023). Sensitization of Gram-Negative Bacteria to Aminoglycosides with 2-Aminoimidazole Adjuvants. Antibiotics. 12(11). 1563–1563.
6.
Wang, Man, Richard D. Smith, Roberta J. Melander, et al.. (2023). Dimeric 2-aminoimidazoles are highly active adjuvants for gram-positive selective antibiotics against Acinetobacter baumannii. European Journal of Medicinal Chemistry. 253. 115329–115329. 10 indexed citations
7.
Melander, Roberta J., et al.. (2022). Overcoming intrinsic resistance in gram-negative bacteria using small molecule adjuvants. Bioorganic & Medicinal Chemistry Letters. 80. 129113–129113. 19 indexed citations
8.
9.
Melander, Roberta J., et al.. (2022). Phenotypic screening of compound libraries as a platform for the identification of antibiotic adjuvants: Identification of colistin adjuvants from a natural product library. Methods in enzymology on CD-ROM/Methods in enzymology. 665. 153–176. 3 indexed citations
10.
Smith, Richard D., et al.. (2022). 6-Bromoindirubin-3′-oxime derivatives are highly active colistin adjuvants against Klebsiella pneumoniae. RSC Medicinal Chemistry. 14(2). 247–252. 1 indexed citations
11.
Rasapalli, Sivappa, et al.. (2020). Synthesis and biofilm inhibition studies of 2-(2-amino-6-arylpyrimidin-4-yl)quinazolin-4(3H)-ones. Bioorganic & Medicinal Chemistry Letters. 30(23). 127550–127550. 13 indexed citations
12.
Smith, Richard D., et al.. (2020). Screening an Established Natural Product Library Identifies Secondary Metabolites That Potentiate Conventional Antibiotics. ACS Infectious Diseases. 6(10). 2629–2640. 22 indexed citations
13.
Melander, Roberta J., Akash Basak, & Christian Melander. (2020). Natural products as inspiration for the development of bacterial antibiofilm agents. Natural Product Reports. 37(11). 1454–1477. 103 indexed citations
14.
Barker, William T., Courtney E. Chandler, Roberta J. Melander, Robert K. Ernst, & Christian Melander. (2019). Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria. Bioorganic & Medicinal Chemistry. 27(9). 1776–1788. 24 indexed citations
15.
Barker, William T., Akash Basak, Courtney E. Chandler, et al.. (2019). Repurposing Eukaryotic Kinase Inhibitors as Colistin Adjuvants in Gram-Negative Bacteria. ACS Infectious Diseases. 5(10). 1764–1771. 28 indexed citations
16.
Basak, Akash, William T. Barker, Leigh A. Jania, et al.. (2019). Structure–Function Studies on IMD‐0354 Identifies Highly Active Colistin Adjuvants. ChemMedChem. 15(2). 210–218. 15 indexed citations
17.
18.
Jeon, Albert B., Andrés Obregón‐Henao, David F. Ackart, et al.. (2017). 2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability. PLoS ONE. 12(7). e0180925–e0180925. 18 indexed citations
19.
Barker, William T., Sara E. Martin, Courtney E. Chandler, et al.. (2017). Small molecule adjuvants that suppress both chromosomal and mcr-1 encoded colistin-resistance and amplify colistin efficacy in polymyxin-susceptible bacteria. Bioorganic & Medicinal Chemistry. 25(20). 5749–5753. 21 indexed citations
20.
Anderson, Ryan G., Aparna Krishnamurthy, Roberta J. Melander, et al.. (2015). Second generation modifiers of colistin resistance show enhanced activity and lower inherent toxicity. Tetrahedron. 72(25). 3549–3553. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven M. Kwasny Breakdown of academic impact, for papers by Roberta J. Melander Breakdown of academic impact, for papers by Shannon B. Falconer Breakdown of academic impact, for papers by Evan Martens Breakdown of academic impact, for papers by Soumya Ramu Breakdown of academic impact, for papers by Maxime Gualtiéri Breakdown of academic impact, for papers by Julieanne M. Bostock Breakdown of academic impact, for papers by Timothy R. Kane Breakdown of academic impact, for papers by Rafael Ayerbe-Algaba Breakdown of academic impact, for papers by Congran Li
Rankless by CCL
2026